Skip to content

Survival Analysis of Non-Small Cell Lung Cancer and the Clinical Efficacy of Fuzheng Jiedu Quyu Prescription in the Whole Intervention

Survival Analysis of Non-Small Cell Lung Cancer and the Clinical Efficacy of Fuzheng Jiedu Quyu Prescription in the Whole Intervention

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038217
Enrollment
Unknown
Registered
2020-09-14
Start date
2020-09-14
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Chinese Medicine Group:Fuzheng Jiedu Quyu Prescription combined with western medicine palliative treatment
Non-Chinese Medicine Group:Western medicine palliative treatment

Sponsors

Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age over 18 years old, regardless of gender; (2) NSCLC patients with clear pathological and cytological diagnosis; (3) Case data can be inquired from the hospital medical record system or medical record room, and the information is complete and the diagnosis and treatment process is detailed; (4) Informed consent to participate in this study, signed informed consent form, good compliance, can be followed up.

Exclusion criteria

Exclusion criteria: (1) Patients with other primary malignant tumors; (2) Those who do not meet the inclusion criteria due to various reasons during the research process; (3) Patients with serious diseases such as heart, brain, liver, kidney and hematopoietic system; (4) Those who cannot cooperate with the researcher for various reasons (such as cerebrovascular accidents, mental disorders, etc.).

Design outcomes

Secondary

MeasureTime frame
Disease progression-free survival time;

Primary

MeasureTime frame
Overall survival;

Countries

China

Contacts

Public ContactChenchen Zhao
1032903124@qq.com+86 15902252036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026